Person who experienced the adverse event (patient)
Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6666045 | 7342669 | I | 6666045-6 | 20100329 | 20100402 | EXP | A0853120A | GLAXOSMITHKLINE | YR | F | Y | 20100402 | CN | 20040109 | UNITED STATES |
Drug(s) used by person
Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
---|---|---|---|---|---|---|---|---|---|---|---|
6666045 | 1013438288 | PS | AVANDIA | 1 | ORAL | 8MG UNKNOWN | 021071 |
Indications of drugs used
Event ID | DRUG SEQ | INDI PT |
---|---|---|
6666045 | 1013438288 | TYPE 2 DIABETES MELLITUS |
Outcome of event
Event ID | OUTC COD |
---|---|
6666045 | DE |
Reactions reported
Event ID | PT |
---|---|
6666045 | DEATH |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|
6666045 | 1013438288 | 20000401 |